BIOMAT Database Logo BIOMAT Database Logo

Experimental studies on the phototoxic effect of cytostatic agents. Results and outlook. 1995

B M Lippert, and W Schade, and S Gottschlich, and J A Werner
Department of Otorhinolaryngology, Head and Neck Surgery, University of Kiel, Germany.

UI MeSH Term Description Entries
D008452 Maximum Allowable Concentration The maximum exposure to a biologically active physical or chemical agent that is allowed during an 8-hour period (a workday) in a population of workers, or during a 24-hour period in the general population, which does not appear to cause appreciable harm, whether immediate or delayed for any period, in the target population. (From Lewis Dictionary of Toxicology, 1st ed) Maximum Permissible Exposure Level,MPEL,Maximum Permissible Exposure Concentration,Allowable Concentration, Maximum,Allowable Concentrations, Maximum,Concentration, Maximum Allowable,Concentrations, Maximum Allowable,MPELs,Maximum Allowable Concentrations
D009055 Mouth The oval-shaped oral cavity located at the apex of the digestive tract and consisting of two parts: the vestibule and the oral cavity proper. Oral Cavity,Cavitas Oris,Cavitas oris propria,Mouth Cavity Proper,Oral Cavity Proper,Vestibule Oris,Vestibule of the Mouth,Cavity, Oral
D009062 Mouth Neoplasms Tumors or cancer of the MOUTH. Cancer of Mouth,Mouth Cancer,Oral Cancer,Oral Neoplasms,Cancer of the Mouth,Neoplasms, Mouth,Neoplasms, Oral,Cancer, Mouth,Cancer, Oral,Cancers, Mouth,Cancers, Oral,Mouth Cancers,Mouth Neoplasm,Neoplasm, Mouth,Neoplasm, Oral,Oral Cancers,Oral Neoplasm
D010778 Photochemotherapy Therapy using oral or topical photosensitizing agents with subsequent exposure to light. Blue Light Photodynamic Therapy,Photodynamic Therapy,Red Light PDT,Red Light Photodynamic Therapy,Therapy, Photodynamic,Light PDT, Red,PDT, Red Light,Photochemotherapies,Photodynamic Therapies,Therapies, Photodynamic
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

B M Lippert, and W Schade, and S Gottschlich, and J A Werner
[Animal experimental studies on the immunosuppressive effect of cytostatic agents].
January 1969, Langenbecks Archiv fur Chirurgie,
B M Lippert, and W Schade, and S Gottschlich, and J A Werner
[Experimental animal studies on the effect of cytostatic ointments. I].
March 1966, Strahlentherapie,
B M Lippert, and W Schade, and S Gottschlich, and J A Werner
[Animal experimental studies on the effect of cytostatic substances on erythropoiesis].
November 1961, Strahlentherapie,
B M Lippert, and W Schade, and S Gottschlich, and J A Werner
[Experimental study on newer cytostatic agents].
February 1962, Orvosi hetilap,
B M Lippert, and W Schade, and S Gottschlich, and J A Werner
[Studies on the phototoxic effect of chlorpromazine].
May 1973, Dermatologische Monatschrift,
B M Lippert, and W Schade, and S Gottschlich, and J A Werner
Solcoseryl effect on the cytostatic and antineoplastic activity of certain cytostatic agents.
January 1987, Acta poloniae pharmaceutica,
B M Lippert, and W Schade, and S Gottschlich, and J A Werner
[Effect of prodigiozan and its combinations with cytostatic agents on experimental tumor growth].
August 1966, Antibiotiki,
B M Lippert, and W Schade, and S Gottschlich, and J A Werner
[Anti-arrhythmia agents: results and outlook].
January 1994, Eksperimental'naia i klinicheskaia farmakologiia,
B M Lippert, and W Schade, and S Gottschlich, and J A Werner
[On the effect of cytostatic agents on human chromosomes].
April 1968, Internationale Zeitschrift fur klinische Pharmakologie, Therapie, und Toxikologie. International journal of clinical pharmacology, therapy, and toxicology,
B M Lippert, and W Schade, and S Gottschlich, and J A Werner
[Histological and enzyme histochemical studies on the effect of some cytostatic agents on the mature rat testis].
January 1967, Acta histochemica,
Copied contents to your clipboard!